Review

Accepted on 17 Apr 2024

Recommendations for nutritional supplements for dry eye disease: current advances

in Inflammation Pharmacology

Ying Cong
Yibing Zhang
Yutong Han
Yunlong Wu
Dan Wang
Bingjie Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1388787

Original Research

Accepted on 12 Apr 2024

Bergamottin (Ber) ameliorates the progression of osteoarthritis via the Sirt1/NF-κB Pathway

in Inflammation Pharmacology

Guangjie Shen
Weihao Zhang
Qiming Tu
Juncheng Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1389786

Review

Published on 10 Apr 2024

Counter-regulatory RAS peptides: new therapy targets for inflammation and fibrotic diseases?

in Inflammation Pharmacology

Diana V. Ávila-Martínez
Wendy K. Mixtega-Ruiz
José M. Hurtado-Capetillo
Oscar Lopez-Franco
Mónica Flores-Muñoz

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1377113

325 views

Systematic Review

Published on 10 Apr 2024

Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis

in Inflammation Pharmacology

Ting Yan
Ting Wang
Mei Tang
Nan Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1372810

228 views

Original Research

Published on 09 Apr 2024

Assessing the impact of body composition, metabolic and oxidative stress parameters on insulin resistance as a prognostic marker for reactive hypoglycemia: a cross-sectional study in overweight, obese, and normal weight individuals

in Inflammation Pharmacology

Maria Kościuszko
Angelika Buczyńska
Katarzyna Łuka
Ewa Duraj
Katarzyna Żuk-Czerniawska
Agnieszka Adamska
Katarzyna Siewko
Aleksandra Wiatr
Adam Jacek Krętowski
Anna Popławska-Kita

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1329802

165 views

Review

Accepted on 08 Apr 2024

Comparative efficacy of five approved Janus kinase inhibitors as monotherapy and combination therapy in patients with moderate-to-severe active rheumatoid arthritis: a systematic review and network meta-analysis of randomized controlled trials

in Inflammation Pharmacology

Wenting Cai
Rui Tong
Sun Yue
Yao Yao
Jinping Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1387585

Editorial

Published on 05 Apr 2024

Editorial: Targeting immune cell metabolism in tissue fibrosis

in Inflammation Pharmacology

Dan Shan
Qianjiang Hu
Chao He
Yong Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1400858

153 views

Original Research

Published on 21 Mar 2024

Novel mechanistic study of HDAC6 regulation of rheumatoid arthritis via CMA: exploring potential therapeutic targets

in Inflammation Pharmacology

Duoduo Lin
Weipeng Lai
Ningning Zheng
Hongbin Luo
Xiaole Chen
Wenzhong Que
Nanwen Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1383663

452 views

Original Research

Published on 21 Mar 2024

PPARδ agonist protects against osteoarthritis by activating AKT/mTOR signaling pathway-mediated autophagy

in Inflammation Pharmacology

Guantong Sun
Xiaodong Li
Pengcheng Liu
Yao Wang
Cheng Yang
Shuhong Zhang
Lei Wang
Xiaoqing Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1336282

497 views

Mini Review

Published on 18 Mar 2024

History and future perspectives of adipose tissue macrophage biology

in Inflammation Pharmacology

Tomonobu Kado
Ayumi Nishimura
Kazuyuki Tobe

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1373182

612 views

Correction

Published on 13 Mar 2024

Corrigendum: Unveiling the therapeutic potential of exogenous β-hydroxybutyrate for chronic colitis in rats: novel insights on autophagy, apoptosis, and pyroptosis

in Inflammation Pharmacology

Rasha Abdelhady
Sameh Saber
Mustafa Ahmed Abdel-Reheim
Mohannad Mohammad S. Alamri
Jaber Alfaifi
Masoud I. E. Adam
Lobna A. Saleh
Azza I. Farag
Elsayed A. Elmorsy
Hend S. El-Wakeel

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1382529

482 views

Systematic Review

Published on 13 Mar 2024

Different biologics for biological-naïve patients with psoriatic arthritis: a systematic review and network meta-analysis

in Inflammation Pharmacology

Jixia Lin
Yougang Ren

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1279525

736 views

Original Research

Published on 29 Feb 2024

Off-label use of Baricitinib improves moderate and severe atopic dermatitis in China through inhibiting MAPK and PI3K/Akt/mTOR pathway via targeting JAK-STAT signaling of CD4+ cells

in Inflammation Pharmacology

Shuang Chen
Caihua Li
Zeng Tu
Tao Cai
Xinying Zhang
Lei Wang
Ruoyuan Tian
Jinglan Huang
Yuxuan Gong
Xiaotong Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1324892

981 views

Original Research

Published on 29 Feb 2024

Modification of 4-(4-chlorothiophen-2-yl)thiazol-2-amine derivatives for the treatment of analgesia and inflammation: synthesis and in vitro, in vivo, and in silico studies

in Inflammation Pharmacology

Mater H. Mahnashi
Umer Rashid
Hassan Hussain Almasoudi
Mohammed H. Nahari
Imran Ahmad
Abdulkarim S. Binshaya
Osama Abdulaziz
Meshari A. Alsuwat
Muhammad Saeed Jan
Abdul Sadiq

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1366695

868 views
1 citation

Review

Published on 23 Feb 2024

Lipotoxicity and immunometabolism in ischemic acute kidney injury: current perspectives and future directions

in Inflammation Pharmacology

Afolarin A. Otunla
Kumaran Shanmugarajah
Alun H. Davies
Joseph Shalhoub

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1355674

697 views

Original Research

Published on 21 Feb 2024

Capsaicin ameliorate pulmonary fibrosis via antioxidant Nrf-2/ PPAR- γ pathway activation and inflammatory TGF-β1/ NF-κB/COX II pathway inhibition

in Inflammation Pharmacology

Wesam H. Abdulaal
Hani Z. Asfour
Nawal Helmi
Hadeel Al Sadoun
Basmah Eldakhakhny
Nabil A. Alhakamy
Hani Mohammed Alqarni
Saeed Ali Mohammed Alzahrani
Mohamed A. El-Moselhy
Sara S. Sharkawi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1333715

1,306 views

Navigation group

Articles

Recommendations for nutritional supplements for dry eye disease: current advances

Bergamottin (Ber) ameliorates the progression of osteoarthritis via the Sirt1/NF-κB Pathway

Counter-regulatory RAS peptides: new therapy targets for inflammation and fibrotic diseases?

Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis

Assessing the impact of body composition, metabolic and oxidative stress parameters on insulin resistance as a prognostic marker for reactive hypoglycemia: a cross-sectional study in overweight, obese, and normal weight individuals

Comparative efficacy of five approved Janus kinase inhibitors as monotherapy and combination therapy in patients with moderate-to-severe active rheumatoid arthritis: a systematic review and network meta-analysis of randomized controlled trials

Editorial: Targeting immune cell metabolism in tissue fibrosis

Novel mechanistic study of HDAC6 regulation of rheumatoid arthritis via CMA: exploring potential therapeutic targets

PPARδ agonist protects against osteoarthritis by activating AKT/mTOR signaling pathway-mediated autophagy

History and future perspectives of adipose tissue macrophage biology

Corrigendum: Unveiling the therapeutic potential of exogenous β-hydroxybutyrate for chronic colitis in rats: novel insights on autophagy, apoptosis, and pyroptosis

Different biologics for biological-naïve patients with psoriatic arthritis: a systematic review and network meta-analysis

Off-label use of Baricitinib improves moderate and severe atopic dermatitis in China through inhibiting MAPK and PI3K/Akt/mTOR pathway via targeting JAK-STAT signaling of CD4+ cells

Modification of 4-(4-chlorothiophen-2-yl)thiazol-2-amine derivatives for the treatment of analgesia and inflammation: synthesis and in vitro, in vivo, and in silico studies

Lipotoxicity and immunometabolism in ischemic acute kidney injury: current perspectives and future directions

Capsaicin ameliorate pulmonary fibrosis via antioxidant Nrf-2/ PPAR- γ pathway activation and inflammatory TGF-β1/ NF-κB/COX II pathway inhibition